Literature DB >> 6172662

Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events.

T Bertani, A Poggi, R Pozzoni, F Delaini, G Sacchi, Y Thoua, G Mecca, G Remuzzi, M B Donati.   

Abstract

Adriamycin has been suspected of causing experimental nephrotoxicity. We report here that adriamycin induces a nephrotic syndrome in rats, proteinuria beginning 4 to 5 days after a single intravenous injection (7.5 mg. per kg. of body weight). The full expression of the syndrome develops 13 to 15 days later. Minimal alterations at light microscopy, negative immunofluorescence, and only some focal "fusion" of foot processes can be observed by electron microscopy in the early phase after injection (28 hours). At 13 days, loss of foot process architecture, and replacement by flattened epithelial cytoplasm, was invariably found. These ultrastructural findings became extensive at 28 days follow-up. Colloidal iron staining of kidney biopsies revealed loss of glomerular polyanions as early as 3 hours and very marked loss at 28 hours after adriamycin injection. Polyanions were totally absent at 13 days and were still undetectable at 28 days. Thus, the loss of polyanionic charges associated with the sialic acid coat precedes the ultrastructural changes and the onset of proteinuria. These changes appeared similar to those reported in rats treated with daunomycin or puromycin animonucleoside. The present study supports in a different animal model the concept that both morphologic changes and proteinuria are the consequence of a common primary event that is the loss of glomerular fixed negative charges.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6172662

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  83 in total

1.  Marker expression, behaviors, and responses vary in different lines of conditionally immortalized cultured podocytes.

Authors:  Seetharamaiah Chittiprol; Phylip Chen; Danica Petrovic-Djergovic; Tad Eichler; Richard F Ransom
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

2.  Glomerular expression of apelin and its association with proteinuria.

Authors:  Yan Bo; Li-Ping Yuan
Journal:  Indian J Pediatr       Date:  2011-11-12       Impact factor: 1.967

3.  Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.

Authors:  Si Ai; Jian Zheng; Qing Lin; Rongyan Chen
Journal:  Clin Exp Nephrol       Date:  2012-07-07       Impact factor: 2.801

4.  Failure of angiotensin converting enzyme inhibition to affect the course of chronic puromycin aminonucleoside nephropathy.

Authors:  G N Marinides; G C Groggel; A H Cohen; T Cook; R L Baranowski; C Westenfelder; W A Border
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

5.  Protective effect of astragalosides from Radix Astragali on adriamycin-induced podocyte injury.

Authors:  Yi-Pa Sai; Yuan-Chun Song; Xing-Xing Chen; Xuan Luo; Jing Liu; Wei-Jing Cui
Journal:  Exp Ther Med       Date:  2018-03-06       Impact factor: 2.447

6.  Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice.

Authors:  Natalia Papeta; Zongyu Zheng; Eric A Schon; Sonja Brosel; Mehmet M Altintas; Samih H Nasr; Jochen Reiser; Vivette D D'Agati; Ali G Gharavi
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

7.  The influence of lipoic acid on adriamycin-induced hyperlipidemic nephrotoxicity in rats.

Authors:  Kumaravel Palanichamy Malarkodi; Andithangal Venkatesan Balachandar; Palaninathan Varlakshmi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

8.  The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat.

Authors:  R H Julicher; L Sterrenberg; G R Haenen; A Bast; J Noordhoek
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

9.  CCNU-adriamycin association induces earlier and more severe nephropathy in rats.

Authors:  G Raguenez-Viotte; M Lahoue; T Ducastelle; J P Morin; J P Fillastre
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

10.  Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance.

Authors:  Gaëlle Brideau; Alain Doucet
Journal:  BMC Nephrol       Date:  2010-07-22       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.